Back to search

Article

Impact of loss-of-function in angiopoietin-like 4 on the human phenome

2024-02-14

Abstract excerpt

<h4>Background</h4> Carriers of the E40K loss-of-function variant in Angiopoietin-like 4 ( ANGPTL4 ), have lower plasma triglyceride levels as well as lower rates of coronary artery disease (CAD) and type 2 diabetes (T2D). These genetic data suggest ANGPTL4 inhibition as a potential therapeutic target for cardiometabolic diseases. However, it is unknown whether the association between E40K and human diseases is du...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2fac0ee5-4588-5ac0-bc68-fd1a4297aabc
DOI
10.1101/2024.02.13.24302776
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of loss-of-function in angiopoietin-like 4 on the human phenomeDOI 10.1101/2024.02.13.24302776
Select a neighboring publication to make it the new centre.